MyFinsight
Home
About
Contact
bcrx: the income statement
Download
Download image
Collaborative And Other
Research And Development
$1,660K
Product
$157,735K
Revenues
$159,395K
(36.14%↑ Y/Y)
Income from operations
$29,591K
(284.70%↑ Y/Y)
Total operating
expenses
$129,804K
(18.66%↑ Y/Y)
Income tax expense
(benefit)
-$769K
(-231.23%↓ Y/Y)
Income (loss) before
income taxes
$12,130K
(190.21%↑ Y/Y)
Total other expense,
net
-$17,461K
Other income
$2,667K
Foreign currency gains
(losses), net
$35K
(-64.29%↓ Y/Y)
Interest income
$2,238K
(-37.68%↓ Y/Y)
Selling, general and
administrative
$83,014K
(27.55%↑ Y/Y)
Research and development
$44,603K
(8.57%↑ Y/Y)
Cost of product sales
$2,187K
(-31.89%↓ Y/Y)
Net income (loss)
$12,899K
(191.92%↑ Y/Y)
Loss on
extinguishment of debt
-$2,740K
Interest expense
$19,661K
(-20.81%↓ Y/Y)
Net comprehensive
income (loss)
$12,393K
(200.78%↑ Y/Y)
Total other
comprehensive (loss) income
-$506K
Unrealized gain (loss) on
available for sale...
$17K
Foreign currency
translation adjustment
-$523K
(-192.90%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
BIOCRYST PHARMACEUTICALS INC (BCRX)
BIOCRYST PHARMACEUTICALS INC (BCRX)